Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8480637
Nanochanneled device and related methods
granted -
US 8470976
Methods and compositions for targeting macromolecules into the nucleus
granted -
US 8470528
Methods and compositions related to adenoassociated virus-phage particles
granted -
US 8466154
Methods and compositions related to wrapping of dehydrons
granted -
US 8455621
Influenza A virus vaccines and inhibitors
granted -
US 8450278
MUC18 targeting peptides
granted -
US 8445491
Wnt protein signalling inhibitors
granted -
US 8440636
Micro-RNA family that modulates fibrosis and uses thereof
granted -
US 8440832
Heterocyclic modulators of cannabinoid receptors
granted -
US 8440460
Methods for transdifferentiating cells
granted -
US 8440168
Image-guided therapy of myocardial disease: composition, manufacturing and applications
granted -
US 8440182
Methods and compositions for treating phenylketonuria
granted -
US 8440208
Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
granted -
US 8435533
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
granted -
US 8435570
Nitrite formulations and their use as nitric oxide prodrugs
granted -
US 8426188
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
granted -
US 8415384
Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade
granted -
US 8399025
Polyamine modified particles
granted -
US 8399421
Treatment for neuropathic pain due to spinal cord injury
granted -
US 8394620
Two-component genome flavivirus and uses thereof
granted -
US 8394583
VH4 codon signature for multiple sclerosis
granted -
US 8383805
RNAi modulation of SCAP and therapeutic uses thereof
granted -
US 8367401
Replication competent hepatitis C virus and methods of use
granted -
US 8361508
Endocytotic particles
granted